Clinical Trial Update: Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dexlansoprazole MR to placebo to maintain healing in subjects with healed erosive esophagitis; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Peptic Esophagitis

Drugs mentioned

• Dexlansoprazole MR (dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Esophagitis, Reflux, Esophagitis, Peptic | Phase 3 | Status: COMPLETED | Results posted: 2009-08-28